scholarly journals Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type

2021 ◽  
Author(s):  
Awad I. Javaid ◽  
Dominique J. Monlezun ◽  
Gloria Iliescu ◽  
Phi Tran ◽  
Alexandru Filipescu ◽  
...  
2021 ◽  
Vol 14 (3) ◽  
pp. 101016 ◽  
Author(s):  
Jim Abraham ◽  
Amy B. Heimberger ◽  
John Marshall ◽  
Elisabeth Heath ◽  
Joseph Drabick ◽  
...  

2021 ◽  
Vol 77 (18) ◽  
pp. 3087
Author(s):  
Naveena Yanamala ◽  
Nanda H. Krishna ◽  
Quincy Hathaway ◽  
Aditya Radhakrishnan ◽  
Srinidhi Sunkara ◽  
...  

Author(s):  
Dhiraj J. Pangal ◽  
Guillaume Kugener ◽  
Shane Shahrestani ◽  
Frank Attenello ◽  
Gabriel Zada ◽  
...  

2021 ◽  
Vol 27 ◽  
pp. 107602962199118
Author(s):  
Logan Ryan ◽  
Samson Mataraso ◽  
Anna Siefkas ◽  
Emily Pellegrini ◽  
Gina Barnes ◽  
...  

Deep venous thrombosis (DVT) is associated with significant morbidity, mortality, and increased healthcare costs. Standard scoring systems for DVT risk stratification often provide insufficient stratification of hospitalized patients and are unable to accurately predict which inpatients are most likely to present with DVT. There is a continued need for tools which can predict DVT in hospitalized patients. We performed a retrospective study on a database collected from a large academic hospital, comprised of 99,237 total general ward or ICU patients, 2,378 of whom experienced a DVT during their hospital stay. Gradient boosted machine learning algorithms were developed to predict a patient’s risk of developing DVT at 12- and 24-hour windows prior to onset. The primary outcome of interest was diagnosis of in-hospital DVT. The machine learning predictors obtained AUROCs of 0.83 and 0.85 for DVT risk prediction on hospitalized patients at 12- and 24-hour windows, respectively. At both 12 and 24 hours before DVT onset, the most important features for prediction of DVT were cancer history, VTE history, and internal normalized ratio (INR). Improved risk stratification may prevent unnecessary invasive testing in patients for whom DVT cannot be ruled out using existing methods. Improved risk stratification may also allow for more targeted use of prophylactic anticoagulants, as well as earlier diagnosis and treatment, preventing the development of pulmonary emboli and other sequelae of DVT.


Sign in / Sign up

Export Citation Format

Share Document